CURO Group Holdings, Corp. (CURO) Sued for Misleading Shareholders About FY 2018 Guidance Shareholders filed a securities fraud class action against CURO, alleging that between April 27, 2018 and October

The Chemours Company (CC) May Have Misled Shareholders  In the 1970s, DuPont’s company scientists became aware that PFAS posed negative health risks, including liver damage and birth defects. To address

Shareholder Alert: Robbins LLP is Investigating the Officers and Directors of Fifth Third Bancorp (FITB) on Behalf of Shareholders July 22, 2020 (San Diego, CA & Cincinnati, OH) – Shareholder

Shareholder Alert: Robbins LLP is Investigating the Officers and Directors of ECMOHO Ltd. (MOHO) on Behalf of Shareholders July 21, 2020 (San Diego, CA & Shanghai, China) – Shareholder rights

Chembio Diagnostics, Inc. (CEMI) Accused of Misleading Shareholders  In March 2020, Chembio entered into a strategic partnership to begin the development of a diagnostic test for the detection of the

Healthcare Services Group, Inc. (HCSG) Fails to Disclose SEC Investigation In March 2017, Monocle Accounting Research issued a report that revealed Healthcare Services had manipulated its reported earnings per share

Verrica Pharmaceuticals Inc. (VRCA) Accused of Misleading Shareholders    On September 16, 2019, Verrica announced it had submitted its New Drug Application (“NDA”) for VP-102 with the U.S. Food &